Healthy Extracts (HYEX) Net Margin (2015 - 2025)

Healthy Extracts' (HYEX) quarterly Net Margin came in at 30.46% in Q4 2025, down 529.0% year-on-year from 7.1% in Q4 2024, and up 57.87% quarter-over-quarter from 72.3% in Q3 2025.

Healthy Extracts (HYEX) Net Margin (2015 - 2025) Analysis & Trends

Healthy Extracts' Net Margin history runs 11 years deep, the most recent figure standing at 30.46% for Q4 2025.

  • On a quarterly basis, Net Margin fell 529.0% year-over-year to 30.46% in Q4 2025; TTM through Dec 2025 was 35.42%, a 1158.0% decrease from a year earlier, with the FY2025 full-year figure at 26.39%, down 1702.0% from the prior year.
  • Net Margin improved to 30.46% in Q4 2025 per HYEX's latest filing, from 72.3% in the prior quarter.
  • Across five years, Net Margin topped out at 3.11% in Q3 2024 and bottomed at 344.47% in Q1 2021.
  • The 5-year median for Net Margin is 48.52% (2023), against an average of 81.71%.
  • Across the five-year window, Net Margin soared 113627 bps in 2021 and plunged 13088 bps in 2023, its largest moves.
  • Year by year, Net Margin stood at 86.39% in 2021, then surged by 72 bps to 24.1% in 2022, then slumped by 120 bps to 53.02% in 2023, then jumped by 53 bps to 25.17% in 2024, then decreased by 21 bps to 30.46% in 2025.
  • Per Business Quant, the three latest HYEX Net Margin figures stand at 30.46% (Q4 2025), 72.3% (Q3 2025), and 20.43% (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 9.29%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 26.57%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -33.66%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 35.18%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 5.03%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 24.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 4.16%
10 Healthy Extracts 14.70 Mn 14.56 Mn 957,429.00 -30.46%

Historic Data

Download Data
DateValue
Dec 31, 2025 -30.46%
Sep 30, 2025 -72.30%
Jun 30, 2025 -20.43%
Mar 31, 2025 -23.68%
Dec 31, 2024 -25.17%
Sep 30, 2024 -3.11%
Jun 30, 2024 -24.41%
Mar 31, 2024 -44.02%
Dec 31, 2023 -53.02%
Sep 30, 2023 -134.13%
Jun 30, 2023 -299.88%
Mar 31, 2023 -66.85%
Dec 31, 2022 -24.10%
Sep 30, 2022 -57.29%
Jun 30, 2022 -169.00%
Mar 31, 2022 -8.28%
Dec 31, 2021 -86.39%
Sep 30, 2021 -42.66%
Jun 30, 2021 -104.44%
Mar 31, 2021 -344.47%